TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
MANE

Veradermics, Incorporated

Healthcare · Biotechnology

117.80$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement MANE
Line item 2023 2024 2025
– – –
– +55.5% +166.6%
– +48.5% +194.2%
– +54.6% +170.2%
– – –
– +1,525.0% -100.0%
– – –
– – –
– – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?